Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.


TSX:BCT - Post by User

Bullboard Posts
Comment by manybearon Feb 03, 2012 9:05am
172 Views
Post# 19484484

RE: RE: NEXT DOOR TO ATC $$$$$$$

RE: RE: NEXT DOOR TO ATC $$$$$$$

Dal Property, Yukon

On March 3rd, Ansell entered into an arms length agreement with Shawn Ryan and Wildwood Exploration Inc. of Whitehorse, Yukon Territory to purchase the Dal property located in the Dawson Mining District of the Yukon Territory.

The Property consists of approximately 178 mineral claims covering an area of approximately 3600 Hectares located within an east-west corridor that hosts ATAC Resources Ltd's Rau Trend (Tiger Zone) to the west and ATAC's Nadaleen Trend (Osiris zone) to the east.  The claims are contiguous to ATAC's property with in the Nadaleen trend.

Historical grab samples taken from outcrops on the Property have yielded high grade gold and copper values.  Two samples taken from a showing in the east of the property assayed 20.37 g/t Au, 10.4% Cu and 8.3 g/t Au, 16.0% Cu respectively. One sample taken from a showing to the west of the property assayed 5.27% Cu.

Bullboard Posts